Cardiovascular and Cerebrovascular Emergency Department Visits Associated With Wildfire Smoke Exposure in California in 2015
Abstract
Background
Wildfire smoke is known to exacerbate respiratory conditions; however, evidence for cardiovascular and cerebrovascular events has been inconsistent, despite biological plausibility.
Methods and Results
A population‐based epidemiologic analysis was conducted for daily cardiovascular and cerebrovascular emergency department (ED) visits and wildfire smoke exposure in 2015 among adults in 8 California air basins. A quasi‐Poisson regression model was used for zip code‐level counts of ED visits, adjusting for heat index, day of week, seasonality, and population. Satellite‐imaged smoke plumes were classified as light, medium, or dense based on model‐estimated concentrations of fine particulate matter. Relative risk was determined for smoky days for lag days 0 to 4. Rates of ED visits by age‐ and sex‐stratified groups were also examined. Rates of all‐cause cardiovascular ED visits were elevated across all lags, with the greatest increase on dense smoke days and among those aged ≥65 years at lag 0 (relative risk 1.15, 95% confidence interval [1.09, 1.22]). All‐cause cerebrovascular visits were associated with smoke, especially among those 65 years and older, (1.22 [1.00, 1.49], dense smoke, lag 1). Respiratory conditions were also increased, as anticipated (1.18 [1.08, 1.28], adults >65 years, dense smoke, lag 1). No association was found for the control condition, acute appendicitis. Elevated risks for individual diagnoses included myocardial infarction, ischemic heart disease, heart failure, dysrhythmia, pulmonary embolism, ischemic stroke, and transient ischemic attack.
Conclusions
Analysis of an extensive wildfire season found smoke exposure to be associated with cardiovascular and cerebrovascular ED visits for all adults, particularly for those over aged 65 years.
Clinical Perspective
What Is New?
•
Wildfire smoke exposure was associated with increased rates of emergency department visits for numerous cardiovascular disease outcomes, including ischemic heart disease, dysrhythmia, heart failure, pulmonary embolism, and stroke.
•
The observed risk was greatest among adults aged>65 years.
•
This analysis used data from nearly the entire wildfire season across a large area of California, which is one of the most extensive studies of wildfire health impacts in California to date.
What Are the Clinical Implications?
•
Individuals with underlying cardiovascular disease risk factors may be at risk for an acute cardiovascular or cerebrovascular event during a period of wildfire smoke exposure.
•
Further studies should explore individual‐level behavioral interventions that may help reduce exposure to smoke during wildfires.
•
Hospital administrators and public health planners may want to use these results to inform surge planning of emergency departments, particularly among stroke centers and hospitals with cardiac catheterization facilities.
Introduction
Wildfire season in North America has increased in intensity and duration, resulting in a greater population at high risk of wildfire smoke exposure.1, 2, 3 Exposure to wildfire smoke is already contributing to substantial clinical, public health, and economic societal burdens, and yet, large‐scale wildfire events are projected to increase through the end of the century in many regions, including in California.2, 4, 5
Wildfire smoke contains numerous air pollutants, including particulate matter, ozone, carbon monoxide, polycyclic aromatic compounds, and nitrogen dioxide, all of which have previously been associated with respiratory and cardiovascular outcomes in health studies of air pollution.6, 7, 8, 9, 10 Fine particulate matter (<2.5 μm in diameter [PM2.5]) is a known respiratory irritant and causally related to cardiovascular morbidity.11, 12, 13 PM2.5 passes deep into the lung and has been shown to increase systemic inflammation, oxidative stress, and coagulation through PM2.5‐mediated changes in the autonomic nervous system.11, 14 This has been linked to cardiovascular health impacts such as ischemic heart disease and cerebrovascular events such as ischemic stroke in the ambient air pollutant PM2.5 literature.11, 15, 16, 17, 18 Other air pollutants in wildfire smoke have also been linked to cardiovascular and respiratory outcomes in urban and ambient air pollution studies, including nitrogen oxides, carbon monoxide, and ozone.7, 8, 9, 10
Among the pollutants during wildfire smoke episodes, fine particulate matter is the primary pollutant of concern to human health because of its abundance.19 It is therefore surprising that the literature is less consistent about the cardiovascular and cerebrovascular effects associated with wildfire smoke exposure.11, 12, 13 In contrast to respiratory impacts, fewer studies have examined cardiovascular and cerebrovascular outcomes and fewer yet reported positive associations with respect to exposure to wildfire smoke, potentially as a result of underpowered studies or limited population exposed, as these studies generally were conducted during solitary wildfire events.11, 12, 20
This study investigates a particularly widespread wildfire season in 2015 in California, during which a series of fire complexes encompassing over 800 000 acres burned in northern and central parts of the state. We examined the relative risk of combined and specific cardiovascular‐, cerebrovascular‐, and respiratory‐related emergency department (ED) visits on light, medium, and dense plumes relative to days without wildfire smoke exposure. Data were used from the entirety of this intense fire season across a vast region of California to elucidate the cardiovascular and cerebrovascular health impacts previously inconclusive in the literature.
Methods
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. The analytic methods and the statistical program code can be made available but access to the data requires institutional review board approval from the Committee for the Protection of Human Subjects (CPHS) under the California Health and Human Services Agency.
Study Setting
All ED visits between May 1 and September 30 were included within 8 of the 15 California air basins in the northern and central regions of the state that were most exposed to smoke during the 2015 wildfire season: Great Basin Valleys, Lake County, Lake Tahoe, Mountain Counties, North Coast, Northeast Plateau, Sacramento Valley, and San Joaquin Valley. The largest and longest fires during this study occurred in the North Coast, Lake County, Sacramento Valley, and San Joaquin Valley air basins but smoke plumes were present in all 8 air basins during the study period. During this period, precipitation was low and present mainly at higher elevations.
Exposure Data
Exposure data were from the publicly available National Oceanic and Atmospheric Administration (NOAA) Hazard Mapping System (HMS) Fire and Smoke product. The HMS provides geospatial boundaries of smoke plumes as seen by visible band satellite imagery. The HMS incorporates data from 7 NOAA and National Aeronautics and Space Administration environmental satellites, recording multiple plumes throughout each day. Each smoke plume in HMS is accompanied by estimated concentrations of PM2.5 attributed to wildfire smoke, generated using atmospheric models, and grouped into light (PM2.5 range 0–10 μg/m3), medium (10.5–21.5 μg/m3), and dense smoke categories (range 22+ μg/m3).21, 22 Daily maximum density of smoke at each zip code was used to characterize exposure. All HMS smoke plume densities are published daily as shapefiles on the NOAA website and are used to communicate smoke plume locations to researchers and the public.
Healthcare Utilization Data
Daily counts of ED visits for each zip code in the study area and period came from the California Office of Statewide Health Planning and Development (OSHPD). The OSHPD Emergency Department Dataset (EDD) and Patient Discharge Dataset (PDD) contain records of over 14 million annual ED visits from hospitals across California. Diagnoses were included for all adults aged ≥19 years. International Classification of Disease, Ninth Edition (ICD‐9) codes were used for diagnoses of interest, using all 25 discharge diagnosis code positions in the OSHPD data set.13, 23, 24, 25, 26 Cardiovascular end points were hypertension (ICD‐9 codes 401–405), myocardial infarction (410), ischemic heart disease (410–411, 413), pulmonary embolism (415), dysrhythmia and conduction disorder (426–427), heart failure (428), peripheral arterial disease (444), and all‐cause cardiovascular (401–405, 410–411, 413, 415, 426–428, 444). Cerebrovascular end points included non‐traumatic subarachnoid hemorrhage (430), intracerebral hemorrhage (431), non‐traumatic intracranial hemorrhage (432), precerebral vascular occlusion (433), ischemic stroke (434), transient ischemic attack (TIA) (435), lateral medullary syndrome (436), and all‐cause cerebrovascular events (430–436). Ischemic stroke and TIA were analyzed individually, while the other outcomes were included only in the all‐cause cerebrovascular category given their rarity. Respiratory end points were included for external validity: asthma (493), COPD (491–492, 496), pneumonia (480–486), other non‐cardiac chest pain or respiratory syndrome (786), and all‐cause respiratory (480–486, 491–493, 496, 786). Control end points were acute appendicitis (540–542) and long‐bone fracture (812–813, 820–821, 823) given their independent pathophysiology from PM2.5‐related inflammation and coagulation, as has been done elsewhere.26 The category of all visits was used to approximate overall ED volume, which included discrete ED visits for any diagnosis code.
Covariate Data
US Census American Communities Survey 2015 population estimates were used for zip code population estimates. Daily mean temperature and relative humidity were obtained for 50 California airports from Weather Underground Data and History Archive. The daily heat index, a combined metric of temperature and relative humidity, was calculated for each zip code based on the mean temperature and relative humidity for the nearest airport to the zip code centroid.27
Statistical Analysis
A population‐based epidemiological analysis was conducted to examine zip code‐level associations between daily maximum smoke density (low, medium, and dense) and ED visits using a quasi‐Poisson regression model. A quasi‐Poisson regression analysis was used to allow for under‐ and over‐dispersion of the data. Each health outcome was analyzed separately and associations were examined for exposure lagged between 0 and 4 days, with each lag analyzed independently. Estimated relative risk (RR) of each health outcome is reported for all adults, as well as for sex‐ and age‐stratified adults. Relative risk is expressed as rate of outcome‐specific ED visits on smoke days relative to the days with no smoke. The statistical model included indicator variables of smoke plume density (light, medium, dense), day of week, and smoothing splines for heat index (3 degrees of freedom) and for temporal trend (3 degrees of freedom), as done elsewhere25, 26 Logged zip code‐population size was used as an offset to adjust for differences in baseline rate of visits by location. The sensitivity of the results was examined for different degrees of freedom for the smoothing splines of the covariates, and Bayesian Information Criteria (BIC) was used to choose the best fitting model.28 No adjustment was made for multiplicity of comparisons.
Statistical analyses were conducted using the R Project for Statistical Computing Version 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria) and emergency department data cleaning and management was conducted with SAS® software, Version 9.4, of the SAS System for Windows (SAS Institute Inc, Cary, NC).
Ethics
The study was approved by the Committee for the Protection of Human Subjects (CPHS) under the California Health and Human Services Agency and the subject informed consent requirement was waived.
Results
Descriptive Statistics
This analysis included 1 196 233 emergency department outcomes that occurred in the study region and time‐period: 361 087 cardiovascular, 15 505 cerebrovascular, and 230 029 respiratory diagnoses, in addition to 2520 acute appendicitis and 13 473 long‐bone fracture diagnoses for the controls. Age‐ and sex‐stratified counts of ED visits delineated by diagnosis categories are shown in Table 1.
ICD‐9 Code | 19 to 44 y | 45 to 64 y | ≥65 y | Female | Male | Total | |
---|---|---|---|---|---|---|---|
All‐cause cardiovascular | 401 to 405, 410 to 411, 413, 415, 426 to 428, 444 | 48 330 | 136 644 | 176 113 | 193 559 | 167 528 | 361 087 |
Hypertension | 401 to 405 | 41 368 | 122 267 | 153 270 | 172 865 | 144 040 | 316 905 |
Ischemic heart disease | 410 to 411, 413 | 808 | 5707 | 11 188 | 7732 | 9971 | 17 703 |
Myocardial infarction | 410 | 436 | 3064 | 5155 | 3630 | 5025 | 8655 |
Pulmonary embolism | 415 | 462 | 1095 | 1485 | 1529 | 1513 | 3042 |
Dysrhythmia and conduction disorder | 426 to 427 | 6522 | 18 823 | 54 467 | 39 012 | 40 800 | 79 812 |
Heart failure | 428 | 3226 | 16 719 | 36 741 | 27 963 | 28 723 | 56 686 |
Peripheral arterial disease | 444 | 54 | 242 | 367 | 286 | 377 | 663 |
All‐cause cerebrovascular | 430 to 436 | 725 | 4276 | 10 504 | 7890 | 7615 | 15 505 |
Subarachnoid hemorrhage (non‐traumatic) | 430 | 72 | 174 | 192 | 268 | 170 | 438 |
Intracerebral/intraventricular hemorrhage | 431 | 95 | 337 | 690 | 516 | 606 | 1122 |
Epidural/subdural hemorrhage (non‐traumatic) | 432 | 81 | 217 | 586 | 358 | 526 | 884 |
Precerebral vascular occlusion | 433 | 63 | 858 | 3783 | 2339 | 2365 | 4704 |
Ischemic stroke | 434 | 281 | 1990 | 3976 | 3117 | 3130 | 6247 |
Transient ischemic attack | 435 | 174 | 992 | 2222 | 1873 | 1515 | 3388 |
Lateral medullary/Wallenberg syndrome | 436 | 8 | 23 | 57 | 49 | 39 | 88 |
All‐cause respiratory | 480 to 486, 491 to 493, 496, 786 | 72 816 | 80 573 | 76 640 | 134 426 | 95 603 | 230 029 |
Asthma | 493 | 35 483 | 26 133 | 17 712 | 53 728 | 25 600 | 79 328 |
COPD | 491 to 492, 496 | 1937 | 20 825 | 32 732 | 28 911 | 26 583 | 55 494 |
Pneumonia | 480 to 486 | 4240 | 7587 | 13 526 | 12 708 | 12 645 | 25 353 |
Other chest/respiratory syndrome | 786 | 35 587 | 35 989 | 25 293 | 54 514 | 42 355 | 96 869 |
Control diagnoses | |||||||
Acute appendicitis | 540 to 542 | 1478 | 707 | 335 | 1198 | 1322 | 2520 |
Long bone fracture | 812 to 813, 820 to 821, 823 | 3110 | 3994 | 6369 | 8374 | 5099 | 13 473 |
All visits | Includes all discrete ED visits | 568 448 | 361 696 | 266 089 | 680 874 | 515 359 | 1 196 233 |
John Wiley & Sons, Ltd
All visits includes all discrete ED visits for any diagnosis in the study region during the same period. COPD indicates chronic obstructive pulmonary disease; ED, emergency department; ICD‐9, International Classification of Disease, Ninth Edition.
Medium‐ and dense‐smoke days were most frequent in August, followed by September (Table 2). Three air basins shared the largest burden of smoke days, including the North Coast, Sacramento Valley, and San Joaquin Valley air basins (Figure 1). These were also the air basins with the largest population centers in the study region.
Smoke Density Estimate | May | June | July | August | Sept. |
---|---|---|---|---|---|
None (%) | 91.6 | 87.2 | 88.4 | 54.1 | 72.7 |
Light (%) | 7.6 | 11.4 | 8.9 | 25.5 | 17.8 |
Medium (%) | 0.8 | 1.3 | 2.4 | 13.3 | 7.5 |
Dense (%) | 0.0 | 0.2 | 0.3 | 7.2 | 2.0 |
Heat index, mean (°F) | 61.1 | 73.3 | 75.1 | 74.3 | 70.1 |
Heat index, maximum (°F) | 83 | 95 | 93 | 91 | 89 |
John Wiley & Sons, Ltd

Cardiovascular Outcomes
ED visits for all‐cause cardiovascular diagnoses and for individual cardiovascular diagnoses were associated with wildfire smoke density for all adults (Table 3, Figure 2) and were more pronounced among adults aged ≥65 years (Tables 4 and 5). Risk increased for all‐cause and individual cardiovascular diagnoses across multiple lags (Figure 3). The greatest change in risk was observed for myocardial infarction (RR [95% confidence interval (CI)]) (1.42 [1.09, 1.84]) and ischemic heart disease (1.22 [1.01, 1.47]) with dense smoke at lag 1, among adults aged ≥65 years. Risk of dysrhythmia was greatest among adults aged ≥65 years on days with dense smoke exposure but was elevated across most lags and smoke densities for all adults and those over aged >65 years. Heart failure was associated most strongly with dense smoke at lag 3 among adults aged ≥65 years (1.22 [1.10, 1.35]) and elevated across all lags. Risk of heart failure was not increased in other age groups (Tables 3 and 4). Associations with all levels of smoke density were observed with hypertension in adults aged ≥65 years, at lags 0 through 4. Increased risk of pulmonary embolism was observed only at lags 2 and 3 with medium and dense smoke, among adults aged ≥65 years (1.71 [1.12, 2.62]).
Outcome | Lag d | 0 | 1 | 2 | 3 | 4 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Smoke Density | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | |
All‐cause cardiovascular | Light | 1.02 | 1.00, 1.03 | 1.04a | 1.03, 1.05a | 1.03a | 1.02, 1.05a | 1.02 | 1.00, 1.03 | 1.01 | 1.00, 1.03 |
Medium | 1.05a | 1.03, 1.08a | 1.05a | 1.03, 1.08a | 1.04a | 1.01, 1.07a | 1.06a | 1.04, 1.09a | 1.06a | 1.03, 1.08a | |
Dense | 1.08a | 1.03, 1.12a | 1.04 | 1.00, 1.09 | 1.07a | 1.03, 1.12a | 1.04 | 1.00, 1.09 | 1.02 | 0.98, 1.06 | |
Hypertension | Light | 1.01 | 1.00, 1.03 | 1.03a | 1.02, 1.05a | 1.03a | 1.02, 1.05a | 1.02 | 1.00, 1.03 | 1.01 | 1.00, 1.03 |
Medium | 1.05a | 1.02, 1.07a | 1.05a | 1.02, 1.07a | 1.04a | 1.01, 1.07a | 1.06a | 1.04, 1.09a | 1.06a | 1.03, 1.08a | |
Dense | 1.08a | 1.03, 1.12a | 1.03 | 0.98, 1.08 | 1.05 | 1.00, 1.10 | 1.03 | 0.99, 1.08 | 1.01 | 0.97, 1.06 | |
Ischemic heart disease | Light | 1.02 | 0.97, 1.08 | 1.02 | 0.97, 1.08 | 1.06 | 1.00, 1.11 | 1.01 | 0.96, 1.06 | 1.02 | 0.97, 1.08 |
Medium | 1.01 | 0.92, 1.11 | 1.03 | 0.94, 1.13 | 1.00 | 0.91, 1.09 | 1.07 | 0.98, 1.17 | 0.95 | 0.87, 1.05 | |
Dense | 1.01 | 0.86, 1.19 | 1.14 | 0.97, 1.33 | 1.16 | 1.00, 1.35 | 1.11 | 0.96, 1.29 | 0.94 | 0.80, 1.11 | |
Myocardial infarction | Light | 1.02 | 0.94, 1.10 | 0.98 | 0.91, 1.06 | 1.03 | 0.95, 1.11 | 1.00 | 0.93, 1.08 | 1.01 | 0.94, 1.09 |
Medium | 1.03 | 0.91, 1.18 | 1.07 | 0.94, 1.22 | 1.05 | 0.92, 1.20 | 1.04 | 0.91, 1.18 | 0.97 | 0.84, 1.11 | |
Dense | 1.05 | 0.83, 1.32 | 1.30a | 1.06, 1.61a | 1.35a | 1.10, 1.65a | 1.22 | 0.98, 1.51 | 1.08 | 0.86, 1.35 | |
Dysrhythmia | Light | 1.06a | 1.04, 1.09a | 1.08a | 1.05, 1.11a | 1.05a | 1.02, 1.08a | 1.04a | 1.01, 1.07a | 1.04a | 1.02, 1.07a |
Medium | 1.10a | 1.05, 1.15a | 1.10a | 1.06, 1.16a | 1.05a | 1.01, 1.10a | 1.09a | 1.05, 1.15a | 1.06a | 1.01, 1.11a | |
Dense | 1.16a | 1.08, 1.25a | 1.04 | 0.96, 1.13 | 1.18a | 1.09, 1.27a | 1.10a | 1.02, 1.19a | 1.04 | 0.97, 1.13 | |
Heart failure | Light | 1.01 | 0.98, 1.04 | 1.03 | 1.00, 1.06 | 1.04a | 1.01, 1.08a | 1.06a | 1.03, 1.09a | 1.03 | 1.00, 1.06 |
Medium | 1.06a | 1.01, 1.12a | 1.06a | 1.01, 1.12a | 1.01 | 0.96, 1.06 | 1.05 | 1.00, 1.10 | 1.08a | 1.02, 1.13a | |
Dense | 1.09 | 1.00, 1.19 | 1.09 | 0.99, 1.19 | 1.10a | 1.01, 1.20a | 1.13a | 1.04, 1.24a | 1.08 | 0.99, 1.18 | |
Pulmonary embolism | Light | 1.04 | 0.91, 1.19 | 1.11 | 0.98, 1.27 | 1.13 | 0.99, 1.29 | 1.09 | 0.95, 1.24 | 1.00 | 0.87, 1.14 |
Medium | 0.98 | 0.77, 1.24 | 1.06 | 0.84, 1.35 | 1.06 | 0.83, 1.34 | 1.21 | 0.97, 1.51 | 1.07 | 0.85, 1.34 | |
Dense | 1.11 | 0.74, 1.65 | 0.93 | 0.60, 1.45 | 1.43 | 1.00, 2.05 | 1.33 | 0.93, 1.92 | 1.02 | 0.68, 1.52 | |
All‐cause cerebrovascular | Light | 1.05 | 1.00, 1.11 | 1.09a | 1.03, 1.15a | 1.05 | 0.99, 1.11 | 1.05 | 1.00, 1.11 | 1.06 | 1.00, 1.12 |
Medium | 1.07 | 0.97, 1.18 | 1.17a | 1.06, 1.28a | 1.08 | 0.98, 1.19 | 1.14a | 1.04, 1.26a | 1.10 | 1.00, 1.21 | |
Dense | 1.12 | 0.95, 1.32 | 1.07 | 0.90, 1.27 | 1.06 | 0.90, 1.26 | 0.97 | 0.82, 1.16 | 0.96 | 0.81, 1.14 | |
Ischemic stroke | Light | 1.04 | 0.96, 1.14 | 1.08 | 0.99, 1.18 | 1.06 | 0.97, 1.16 | 1.08 | 0.99, 1.18 | 1.08 | 0.99, 1.17 |
Medium | 1.03 | 0.88, 1.20 | 1.10 | 0.94, 1.28 | 1.05 | 0.90, 1.23 | 1.16 | 1.00, 1.34 | 1.09 | 0.94, 1.27 | |
Dense | 1.11 | 0.86, 1.45 | 1.03 | 0.78, 1.36 | 0.96 | 0.72, 1.27 | 0.94 | 0.71, 1.25 | 0.96 | 0.73, 1.27 | |
Transient ischemic attack | Light | 1.00 | 0.89, 1.13 | 1.01 | 0.89, 1.14 | 1.01 | 0.89, 1.14 | 1.05 | 0.93, 1.18 | 1.03 | 0.91, 1.16 |
Medium | 1.14 | 0.94, 1.40 | 1.14 | 0.93, 1.40 | 1.01 | 0.82, 1.25 | 1.22 | 1.00, 1.49 | 1.08 | 0.88, 1.33 | |
Dense | 1.23 | 0.87, 1.73 | 0.92 | 0.62, 1.37 | 1.07 | 0.74, 1.54 | 0.98 | 0.67, 1.43 | 0.90 | 0.61, 1.33 | |
All‐cause respiratory | Light | 1.02 | 1.00, 1.04 | 1.04a | 1.02, 1.06a | 1.03a | 1.01, 1.05a | 1.02 | 1.00, 1.03 | 1.00 | 0.98, 1.02 |
Medium | 1.09a | 1.05, 1.12a | 1.08a | 1.05, 1.11a | 1.05a | 1.02, 1.08a | 1.08a | 1.05, 1.12a | 1.07a | 1.04, 1.10a | |
Dense | 1.09a | 1.03, 1.15a | 1.10a | 1.04, 1.16a | 1.09a | 1.04, 1.15a | 1.10a | 1.05, 1.16a | 1.04 | 0.99, 1.10 | |
Acute appendicitis | Light | 1.07 | 0.92, 1.26 | 0.99 | 0.84, 1.17 | 1.11 | 0.95, 1.31 | 1.00 | 0.84, 1.17 | 0.95 | 0.81, 1.12 |
Medium | 0.79 | 0.57, 1.08 | 1.12 | 0.85, 1.47 | 0.83 | 0.60, 1.14 | 0.84 | 0.62, 1.15 | 0.96 | 0.72, 1.28 | |
Dense | 0.83 | 0.48, 1.43 | 0.92 | 0.54, 1.56 | 1.28 | 0.81, 2.02 | 1.00 | 0.60, 1.67 | 1.01 | 0.61, 1.68 | |
Long bone fractures | Light | 1.09a | 1.02, 1.16a | 1.10a | 1.03, 1.17a | 1.04 | 0.97, 1.11 | 1.04 | 0.97, 1.11 | 1.02 | 0.95, 1.09 |
Medium | 1.12 | 1.00, 1.26 | 1.09 | 0.97, 1.22 | 1.05 | 0.94, 1.18 | 1.01 | 0.90, 1.13 | 1.04 | 0.92, 1.16 | |
Dense | 1.31a | 1.09, 1.56a | 1.30a | 1.09, 1.56a | 1.22a | 1.01, 1.47a | 0.96 | 0.78, 1.18 | 1.12 | 0.92, 1.36 |
John Wiley & Sons, Ltd
Models adjusted for heat index, day of week, time trend, and log‐population offset. CI indicates confidence interval; RR, relative risk.
a
Statistically significant relative risks.

Outcome | Lag (Days) | 0 | 1 | 2 | 3 | 4 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Smoke Density | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | |
All‐cause cardiovascular | Light | 0.99 | 0.97, 1.01 | 1.02 | 1.00, 1.04 | 1.01 | 0.99, 1.03 | 1.00 | 0.98, 1.02 | 1.00 | 0.98, 1.02 |
Medium | 1.03 | 0.99, 1.07 | 1.01 | 0.97, 1.05 | 1.00 | 0.96, 1.04 | 1.05a | 1.01, 1.09a | 1.04 | 1.00, 1.08 | |
Dense | 1.03 | 0.96, 1.10 | 0.98 | 0.92, 1.05 | 1.04 | 0.97, 1.11 | 1.01 | 0.95, 1.08 | 0.96 | 0.90, 1.03 | |
Hypertension | Light | 0.99 | 0.96, 1.01 | 1.02 | 1.00, 1.04 | 1.01 | 0.99, 1.03 | 1.00 | 0.98, 1.02 | 1.00 | 0.97, 1.02 |
Medium | 1.03 | 0.99, 1.07 | 1.01 | 0.97, 1.05 | 1.00 | 0.96, 1.04 | 1.05a | 1.01, 1.10a | 1.05a | 1.01, 1.09a | |
Dense | 1.03 | 0.96, 1.10 | 0.97 | 0.90, 1.04 | 1.03 | 0.96, 1.10 | 1.01 | 0.94, 1.08 | 0.96 | 0.89, 1.03 | |
Ischemic heart disease | Light | 0.97 | 0.88, 1.08 | 0.95 | 0.86, 1.05 | 1.03 | 0.93, 1.13 | 0.99 | 0.90, 1.09 | 1.09 | 0.99, 1.20 |
Medium | 0.94 | 0.79, 1.12 | 0.98 | 0.82, 1.16 | 0.96 | 0.80, 1.14 | 0.96 | 0.81, 1.14 | 0.94 | 0.79, 1.12 | |
Dense | 0.85 | 0.62, 1.18 | 0.95 | 0.70, 1.29 | 1.21 | 0.93, 1.59 | 1.22 | 0.94, 1.59 | 1.06 | 0.80, 1.41 | |
Myocardial infarction | Light | 1.01 | 0.89, 1.15 | 0.92 | 0.80, 1.05 | 1.04 | 0.91, 1.19 | 1.04 | 0.91, 1.18 | 1.05 | 0.92, 1.20 |
Medium | 0.93 | 0.74, 1.18 | 1.00 | 0.79, 1.25 | 1.02 | 0.81, 1.28 | 0.89 | 0.70, 1.14 | 0.94 | 0.74, 1.19 | |
Dense | 0.96 | 0.63, 1.44 | 1.13 | 0.78, 1.65 | 1.33 | 0.94, 1.89 | 1.28 | 0.89, 1.82 | 1.13 | 0.78, 1.66 | |
Dysrhythmia | Light | 1.02 | 0.97, 1.08 | 1.05 | 0.99, 1.10 | 1.02 | 0.97, 1.07 | 1.02 | 0.97, 1.07 | 1.06a | 1.01, 1.11a |
Medium | 1.09 | 1.00, 1.19 | 1.06 | 0.97, 1.16 | 0.98 | 0.89, 1.08 | 1.08 | 0.99, 1.18 | 0.95 | 0.87, 1.04 | |
Dense | 1.05 | 0.90, 1.23 | 1.03 | 0.88, 1.21 | 1.16 | 1.00, 1.34 | 1.03 | 0.88, 1.20 | 1.02 | 0.88, 1.20 | |
Heart failure | Light | 0.99 | 0.94, 1.04 | 1.02 | 0.97, 1.08 | 1.00 | 0.95, 1.05 | 1.03 | 0.98, 1.09 | 1.01 | 0.96, 1.07 |
Medium | 1.01 | 0.92, 1.11 | 1.02 | 0.93, 1.12 | 0.97 | 0.88, 1.06 | 1.02 | 0.93, 1.11 | 1.02 | 0.93, 1.12 | |
Dense | 0.91 | 0.76, 1.08 | 1.02 | 0.86, 1.20 | 1.06 | 0.91, 1.25 | 1.02 | 0.87, 1.20 | 0.98 | 0.83, 1.16 | |
Pulmonary embolism | Light | 0.84 | 0.65, 1.11 | 1.05 | 0.82, 1.35 | 1.00 | 0.78, 1.30 | 1.09 | 0.85, 1.40 | 0.96 | 0.74, 1.24 |
Medium | 1.00 | 0.65, 1.54 | 0.80 | 0.49, 1.32 | 1.01 | 0.65, 1.58 | 1.07 | 0.69, 1.64 | 1.23 | 0.83, 1.83 | |
Dense | 1.22 | 0.60, 2.45 | 0.94 | 0.42, 2.09 | 1.19 | 0.59, 2.40 | 1.27 | 0.65, 2.50 | 0.77 | 0.33, 1.77 | |
All‐cause cerebrovascular | Light | 1.03 | 0.93, 1.14 | 1.10 | 1.00, 1.22 | 1.01 | 0.91, 1.12 | 0.97 | 0.87, 1.07 | 0.99 | 0.89, 1.10 |
Medium | 0.99 | 0.83, 1.19 | 1.12 | 0.94, 1.33 | 1.02 | 0.85, 1.23 | 1.12 | 0.94, 1.33 | 1.01 | 0.85, 1.21 | |
Dense | 0.91 | 0.65, 1.28 | 0.66 | 0.44, 0.99 | 1.10 | 0.80, 1.49 | 1.01 | 0.74, 1.38 | 0.83 | 0.59, 1.17 | |
Ischemic stroke | Light | 1.01 | 0.87, 1.18 | 1.05 | 0.91, 1.22 | 0.94 | 0.80, 1.10 | 0.93 | 0.80, 1.09 | 1.01 | 0.86, 1.17 |
Medium | 0.91 | 0.69, 1.20 | 0.99 | 0.76, 1.30 | 1.00 | 0.77, 1.31 | 0.99 | 0.76, 1.29 | 1.05 | 0.81, 1.36 | |
Dense | 0.84 | 0.50, 1.42 | 0.57 | 0.30, 1.08 | 0.90 | 0.55, 1.48 | 0.70 | 0.40, 1.20 | 0.64 | 0.36, 1.13 | |
Transient ischemic attack | Light | 1.13 | 0.92, 1.38 | 1.20 | 0.99, 1.46 | 1.07 | 0.88, 1.31 | 1.04 | 0.84, 1.27 | 0.94 | 0.77, 1.16 |
Medium | 1.13 | 0.80, 1.60 | 1.12 | 0.79, 1.60 | 1.05 | 0.73, 1.50 | 1.39a | 1.01, 1.92a | 0.93 | 0.65, 1.34 | |
Dense | 1.23 | 0.68, 2.22 | 0.63 | 0.28, 1.45 | 1.17 | 0.63, 2.15 | 1.12 | 0.60, 2.06 | 0.88 | 0.45, 1.70 | |
All‐cause respiratory | Light | 1.00 | 0.97, 1.03 | 1.03 | 1.00, 1.06 | 1.02 | 0.99, 1.05 | 1.01 | 0.98, 1.04 | 1.00 | 0.97, 1.03 |
Medium | 1.08a | 1.03, 1.13a | 1.09a | 1.03, 1.14a | 1.04 | 0.99, 1.09 | 1.10a | 1.05, 1.15a | 1.07a | 1.02, 1.12a | |
Dense | 1.06 | 0.98, 1.16 | 1.07 | 0.98, 1.16 | 1.09 | 1.00, 1.18 | 1.07 | 0.98, 1.16 | 1.04 | 0.96, 1.14 | |
Acute appendicitis | Light | 1.20 | 0.85, 1.70 | 1.17 | 0.82, 1.66 | 1.14 | 0.80, 1.63 | 1.05 | 0.74, 1.51 | 1.07 | 0.74, 1.53 |
Medium | 1.11 | 0.59, 2.08 | 1.29 | 0.71, 2.33 | 0.84 | 0.42, 1.71 | 0.69 | 0.32, 1.48 | 1.36 | 0.76, 2.44 | |
Dense | 1.48 | 0.57, 3.82 | 1.53 | 0.59, 3.97 | 1.59 | 0.63, 4.01 | 1.55 | 0.61, 3.90 | 1.21 | 0.42, 3.45 | |
Long bone fracture | Light | 1.06 | 0.95, 1.19 | 1.14a | 1.02, 1.27a | 1.08 | 0.97, 1.21 | 1.13a | 1.01, 1.26a | 1.02 | 0.91, 1.14 |
Medium | 1.16 | 0.97, 1.39 | 1.10 | 0.91, 1.32 | 1.06 | 0.88, 1.28 | 1.04 | 0.85, 1.26 | 0.97 | 0.80, 1.18 | |
Dense | 1.12 | 0.82, 1.54 | 1.14 | 0.83, 1.56 | 1.46a | 1.10, 1.95a | 0.85 | 0.59, 1.23 | 0.92 | 0.64, 1.31 |
John Wiley & Sons, Ltd
Models adjusted for heat index, day of week, time trend, and log‐population offset. CI indicates confidence interval; RR, relative risk.
a
Statistically significant relative risks.
Outcome | Lag (Days) | 0 | 1 | 2 | 3 | 4 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Smoke Density | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | |
All‐cause cardiovascular | Light | 1.06a | 1.04, 1.08a | 1.07a | 1.05, 1.09a | 1.06a | 1.04, 1.08a | 1.03a | 1.02, 1.05a | 1.03a | 1.01, 1.05a |
Medium | 1.09a | 1.05, 1.12a | 1.10a | 1.06, 1.13a | 1.08a | 1.05, 1.12a | 1.08a | 1.04, 1.11a | 1.07a | 1.04, 1.11a | |
Dense | 1.15a | 1.09, 1.22a | 1.12a | 1.06, 1.18a | 1.13a | 1.07, 1.20a | 1.10a | 1.05, 1.17a | 1.05 | 1.00, 1.11 | |
Hypertension | Light | 1.05a | 1.03, 1.07a | 1.06a | 1.04, 1.08a | 1.06a | 1.04, 1.08a | 1.04a | 1.02, 1.06a | 1.03a | 1.01, 1.05a |
Medium | 1.08a | 1.04, 1.11a | 1.09a | 1.05, 1.12a | 1.08a | 1.05, 1.12a | 1.07a | 1.03, 1.10a | 1.07a | 1.04, 1.11a | |
Dense | 1.15a | 1.09, 1.21a | 1.10a | 1.04, 1.17a | 1.10a | 1.04, 1.16a | 1.08a | 1.03, 1.15a | 1.04 | 0.98, 1.10 | |
Ischemic heart disease | Light | 1.04 | 0.98, 1.11 | 1.07 | 1.00, 1.14 | 1.06 | 1.00, 1.13 | 1.02 | 0.95, 1.09 | 1.00 | 0.93, 1.06 |
Medium | 1.01 | 0.90, 1.14 | 1.06 | 0.94, 1.18 | 1.00 | 0.89, 1.13 | 1.12 | 1.00, 1.25 | 0.96 | 0.85, 1.08 | |
Dense | 1.10 | 0.90, 1.33 | 1.22a | 1.01, 1.47a | 1.15 | 0.95, 1.39 | 1.07 | 0.89, 1.30 | 0.89 | 0.72, 1.09 | |
Myocardial infarction | Light | 1.02 | 0.93, 1.13 | 1.02 | 0.92, 1.12 | 1.01 | 0.91, 1.11 | 0.98 | 0.88, 1.08 | 0.99 | 0.90, 1.09 |
Medium | 1.05 | 0.89, 1.25 | 1.08 | 0.91, 1.28 | 1.05 | 0.89, 1.25 | 1.13 | 0.96, 1.34 | 0.96 | 0.81, 1.15 | |
Dense | 1.10 | 0.82, 1.48 | 1.42a | 1.09, 1.84a | 1.37a | 1.05, 1.78a | 1.20 | 0.91, 1.59 | 1.09 | 0.82, 1.46 | |
Dysrhythmia | Light | 1.08a | 1.04, 1.11a | 1.10a | 1.06, 1.13a | 1.07a | 1.03, 1.10a | 1.05a | 1.02, 1.09a | 1.04a | 1.01, 1.08a |
Medium | 1.12a | 1.06, 1.18a | 1.13a | 1.07, 1.19a | 1.09a | 1.03, 1.15a | 1.09a | 1.03, 1.16a | 1.09a | 1.03, 1.15a | |
Dense | 1.24a | 1.13, 1.36a | 1.07 | 0.96, 1.18 | 1.19a | 1.09, 1.31a | 1.15a | 1.05, 1.26a | 1.04 | 0.95, 1.15 | |
Heart failure | Light | 1.04 | 1.00, 1.07 | 1.05a | 1.01, 1.09a | 1.07a | 1.04, 1.11a | 1.06a | 1.03, 1.10a | 1.05a | 1.01, 1.09a |
Medium | 1.10a | 1.03, 1.17a | 1.10a | 1.03, 1.17a | 1.03 | 0.97, 1.10 | 1.07 | 1.00, 1.14 | 1.11a | 1.04, 1.18a | |
Dense | 1.20a | 1.08, 1.33a | 1.16a | 1.04, 1.30a | 1.15a | 1.03, 1.28a | 1.22a | 1.10, 1.35a | 1.11 | 1.00, 1.24 | |
Pulmonary embolism | Light | 1.12 | 0.95, 1.32 | 1.15 | 0.97, 1.35 | 1.21a | 1.03, 1.42a | 1.08 | 0.92, 1.28 | 0.97 | 0.82, 1.15 |
Medium | 0.82 | 0.59, 1.13 | 1.26 | 0.95, 1.66 | 1.14 | 0.85, 1.53 | 1.39a | 1.06, 1.81a | 1.00 | 0.74, 1.34 | |
Dense | 1.03 | 0.61, 1.72 | 1.00 | 0.58, 1.74 | 1.71a | 1.12, 2.62a | 1.55a | 1.01, 2.37a | 1.20 | 0.75, 1.93 | |
All‐cause cerebrovascular | Light | 1.07 | 1.00, 1.15 | 1.09a | 1.01, 1.16a | 1.05 | 0.98, 1.13 | 1.08a | 1.01, 1.16a | 1.08a | 1.01, 1.16a |
Medium | 1.12 | 1.00, 1.26 | 1.21a | 1.08, 1.35a | 1.12 | 0.99, 1.26 | 1.16a | 1.04, 1.30a | 1.12 | 1.00, 1.26 | |
Dense | 1.22 | 1.00, 1.48 | 1.22 | 1.00, 1.49 | 1.08 | 0.88, 1.33 | 0.98 | 0.79, 1.21 | 1.03 | 0.84, 1.27 | |
Ischemic stroke | Light | 1.07 | 0.96, 1.20 | 1.08 | 0.96, 1.21 | 1.12 | 1.00, 1.25 | 1.16a | 1.04, 1.29a | 1.11 | 1.00, 1.24 |
Medium | 1.12 | 0.93, 1.36 | 1.16 | 0.96, 1.41 | 1.07 | 0.88, 1.31 | 1.25a | 1.04, 1.50a | 1.07 | 0.88, 1.30 | |
Dense | 1.25 | 0.91, 1.71 | 1.26 | 0.92, 1.73 | 0.95 | 0.66, 1.35 | 1.08 | 0.77, 1.52 | 1.08 | 0.78, 1.51 | |
Transient ischemic attack | Light | 0.96 | 0.82, 1.13 | 0.96 | 0.82, 1.13 | 0.96 | 0.82, 1.13 | 1.06 | 0.91, 1.24 | 1.04 | 0.89, 1.22 |
Medium | 1.18 | 0.91, 1.53 | 1.16 | 0.89, 1.51 | 1.04 | 0.79, 1.37 | 1.19 | 0.91, 1.54 | 1.17 | 0.90, 1.52 | |
Dense | 1.30 | 0.85, 2.01 | 1.09 | 0.68, 1.75 | 1.12 | 0.71, 1.79 | 0.93 | 0.57, 1.54 | 0.94 | 0.57, 1.53 | |
All‐cause respiratory | Light | 1.07a | 1.04, 1.10a | 1.08a | 1.05, 1.11a | 1.06a | 1.04, 1.09a | 1.03 | 1.00, 1.06 | 1.02 | 0.99, 1.05 |
Medium | 1.12a | 1.07, 1.18a | 1.11a | 1.06, 1.17a | 1.08a | 1.03, 1.14a | 1.09a | 1.04, 1.14a | 1.08a | 1.03, 1.13a | |
Dense | 1.14a | 1.05, 1.24a | 1.18a | 1.08, 1.28a | 1.15a | 1.06, 1.25a | 1.19a | 1.10, 1.29a | 1.07 | 0.99, 1.17 | |
Acute appendicitis | Light | 1.10 | 0.69, 1.75 | 1.07 | 0.67, 1.69 | 1.46 | 0.95, 2.24 | 1.02 | 0.65, 1.61 | 0.90 | 0.56, 1.44 |
Medium | 0.99 | 0.42, 2.34 | 0.89 | 0.37, 2.15 | 0.86 | 0.34, 2.20 | 0.73 | 0.29, 1.83 | 0.72 | 0.29, 1.78 | |
Dense | 1.27 | 0.35, 4.65 | 0.52 | 0.07, 3.83 | 0.79 | 0.15, 4.16 | 0.42 | 0.06, 3.04 | 0.85 | 0.21, 3.48 | |
Long bone fracture | Light | 1.12a | 1.02, 1.24a | 1.11 | 1.00, 1.22 | 1.06 | 0.96, 1.17 | 1.03 | 0.93, 1.14 | 1.11 | 1.00, 1.22 |
Medium | 1.09 | 0.92, 1.30 | 1.06 | 0.89, 1.27 | 1.00 | 0.84, 1.20 | 1.04 | 0.87, 1.23 | 1.10 | 0.93, 1.31 | |
Dense | 1.46a | 1.12, 1.90a | 1.47a | 1.12, 1.92a | 1.05 | 0.77, 1.43 | 1.15 | 0.86, 1.54 | 1.24 | 0.94, 1.64 |
John Wiley & Sons, Ltd
Models adjusted for heat index, day of week, time trend, and log‐population offset. CI indicates confidence interval; RR, relative risk ratio.
a
Statistically significant relative risks.

Cerebrovascular Outcomes
Risk of all‐cause cerebrovascular ED visits on smoky days was most pronounced among adults aged ≥65 years and persisted at lag days 0 through 4 (Tables 3, 4 through 5, Figure 2). Increased risk was observed with all 3 levels of smoke density, although not consistently statistically significant, possibly because of the fewer number of cerebrovascular events. Among adults aged >65 years, the highest relative risk was observed at dense smoke levels on lag day 0 (1.22 [1.00, 1.48]) and lag day 1 (1.22 [1.00, 1.49]). However, elevated risks were also seen for all adults and light smoke (1.09 [1.03, 1.15]) and medium smoke at lag days 1 and 3 (1.17 [1.06, 1.28], 1.14 [1.04, 1.26)]) (Table 3). In contrast, ischemic stroke diagnoses were increased only at longer lags and driven by the ≥65 age group. Among adults aged ≥65, ischemic stroke was statistically significant at lag 3 for light (1.16 [1.04, 1.29]) and medium smoke (1.25 [1.04, 1.50]), and was also increased for all adults at lag 3 days (1.16 [1.00, 1.34]) and adults 19 to 44 years at lag 4 (1.90 [1.26, 2.85]) (Table S1). Associations with transient ischemic attack were significant only among adults 45 to 64 and medium smoke at lag day 3 (1.39 [1.01, 1.92]) and consistently increased but with wider CIs for older populations at multiple lags (Tables 4 and 5).
Respiratory and Control Outcomes
All‐cause respiratory outcomes were increased with medium and dense smoke exposure (Table 3), but most pronounced in adults aged ≥65 years (Figure 2). The risk of asthma related ED visits among younger adults on medium and dense smoke plume days was the highest but was elevated in other age groups as well (Table S1). Risk for COPD and pneumonia were increased across multiple lags and highest on dense smoke days for adults aged ≥65 years (Table S1). Statistically significant differences were not found among sex‐stratified results for these respiratory diagnoses (Table S2).
No association was found between wildfire smoke density and acute appendicitis diagnoses. Long‐bone fractures, however, were observed to have a significant association with PM2.5 among all adults at lags 0 through 2 and dense smoke (1.31 [1.09, 1.56]), primarily adults 65 years and older (1.47 [1.12, 1.92]). When stratified by sex, the association was significant among women (1.37 [1.09, 1.70]) but not among men (1.22 [0.90, 1.65]) (Table S2).
Sensitivity Analysis
Additional sensitivity analysis was conducted by assessing zip code‐specific associations between wildfire smoke density and health outcomes and summarizing results using random‐effects meta‐analysis to account for possible geographic heterogeneity of outcomes (Table S3). Sparsely populated zip codes had too low a count of diagnoses to perform the analysis so a population cutoff of 13 250 per zip code was used. The results are generally consistent with those presented here, with smaller standard errors, since the data were subset to larger zip code populations. Additional sensitivity analysis was conducting using the zip code‐specific proportion of the population below the poverty level and the results were also consistent with those of the original analysis.
Additional age‐ and sex‐stratified results, and those of rarer outcomes, can be found in Tables S1 and S2.
Discussion
In this investigation, a positive association was found between wildfire smoke density and ED visits attributable to cardiovascular, cerebrovascular, and respiratory disease in northern and central California in the summer of 2015. The impacts were greatest on medium and dense smoke days and among adults aged ≥65 years, although also observed among younger age groups for some clinical conditions. In addition to the all‐cause cardiovascular and cerebrovascular categories, relative risk was elevated for specific outcomes including myocardial infarction, ischemic heart disease, dysrhythmia, heart failure, pulmonary embolism, ischemic stroke, and transient ischemic attack. All‐cause respiratory outcomes were statistically significant as well and surprisingly, so were long‐bone fractures. No association was found with the control condition of acute appendicitis.
The evidence for particulate matter‐mediated mechanisms for cardiovascular disease has been discussed elsewhere.18 Recent reviews on the topic have identified 3 main pathophysiologic mechanisms: modulation of autonomic balance and neural input to the heart, release of pro‐inflammatory mediators by lung tissue with attendant systemic effects, and penetration of particulate matter into the systemic circulation.18, 29, 30, 31, 32, 33, 34 These 3 pathways can lead to an increase in systemic oxidative stress, endothelial dysfunction, and other inflammatory responses, in addition to platelet activation, hypercoagulability, and vasoconstriction.18, 29, 30 Acute PM2.5 exposure and the resulting autonomic stimulation, pro‐coagulability, and inflammation all favor the underlying pathophysiology of the cardiovascular disease outcomes observed in this investigation, including cardiac dysrhythmia, ischemic heart disease, heart failure exacerbation, pulmonary embolism, and cerebrovascular events.
These pathophysiologic mechanisms are consistent with the apparent triggering of cardiovascular and cerebrovascular clinical events based on the temporal relationships observed between short‐term exposures to wildfire smoke and the clinical outcomes.35 Dysrhythmia, likely precipitated by immediate changes in the balance of the autonomic nervous system, first appeared at lag 0.36 Myocardial infarction and ischemic heart disease appeared second at lag 1. Epidemiologic studies indicate that ambient particulate matter exposure is more strongly associated with ST‐elevation myocardial infarction than non‐ST‐elevation myocardial infarction, suggesting that the mechanism is dependent upon erosion of a rupture‐prone plaque and changes in the balance of pro‐thrombotic and anti‐thrombotic processes promoting more extensive thrombosis.37 ED visits for heart failure appeared first at lag 0 and increased with time, with the highest RR at lag 3. In contrast to the mechanisms accounting for the triggering of myocardial infarction, hospitalizations for heart failure are most likely secondary to exacerbations of pre‐existing heart failure worsened by PM‐induced increases in systemic blood pressure, and systemic and pulmonary vasoconstriction.38, 39, 40, 41 All these outcomes were most strongly associated with the aged. Cerebrovascular responses primarily manifested among older people and appeared within the first day and continued through lag 4, consistent with endothelial dysfunction and vasoconstriction, as well as thromboembolic phenomena.
Studies of wildfire‐related cardiovascular outcomes have reported inconsistent findings. One recent review found that most studies with combined cardiovascular outcomes have found no significant associations, although some specific outcomes have been shown to be increased in the context of wildfire smoke, such as out‐of‐hospital cardiac arrest, heart failure, and ischemic heart disease.11 Another review found that 6 of 14 studies revealed statistically significant associations of wildfires and cardiovascular outcomes.12 Since the publication of that review, however, at least 4 subsequent investigations have identified elevated risk of cardiovascular events associated with wildfire smoke exposure, which may reflect recent use of more sophisticated methods or utilization of more specific outcomes.15, 20, 26, 42
With respect to specific cardiovascular diagnoses, previous research has shown mixed results on ischemic heart disease. No association was found with wildfire smoke and ischemic heart disease hospitalizations in California, while another study found an increase in clinic‐based ischemic heart disease visits among Native Americans of the Hoopa tribe of northern California.43, 44 An Australian study mentioned earlier found increased rates of hospital admissions and ED visits for ischemic heart disease among women and adults aged >65 years at lag day 2.15
Similarly, heart failure was found to be associated with wildfire smoke in this study. Elsewhere, heart failure‐related ED visits were elevated in the context of peat bog fires in North Carolina in 2008, but the association was not significant when repeated for fires in 2011 and only suggestive among wildfires in 1 study from California.15, 16, 26, 43, 45 Other cardiovascular outcomes, such as cardiac dysrhythmia, or pulmonary embolism, have not been found to have a clear association with wildfire‐PM2.5, although some suggestive effects have been found for dysrhythmia.26, 43, 46 This investigation contributes to those significant findings of dysrhythmia and pulmonary embolism, but no association was found with peripheral arterial disease, potentially because of a small number of related ED visits.
Hypertension is another cardiovascular outcome that some have found to have a significant association with wildfire‐PM2.5 and may play an important role in the pathogenesis of more significant cardiovascular outcomes, such as ischemic heart disease and non‐traumatic intracranial hemorrhage.25, 26 In this study, significant associations were also found between wildfire smoke and hypertension diagnoses in the ED.
In contrast to the evidence from the ambient PM2.5 literature, few studies discussed cerebrovascular impacts associated with wildfire‐PM2.5, and mostly in the context of all cardiovascular disease outcomes combined.8, 18 This study is one of the few to explicitly investigate cerebrovascular outcomes and to find significant associations with smoke density defined by wildfire‐PM2.5. Of 3 studies that described this association, only 1 found elevated impacts.43, 46, 47 Another study of 1 wildfire season in New Mexico found statistically significant elevated rates among adults aged 20 to 64 years (1.69 [1.03–2.77]) during the fire period.20
While the aim of this study was to explore cardiovascular and cerebrovascular health impacts attributable to wildfire smoke, respiratory outcomes were included for external validity, given the strong associations between wildfire‐PM2.5 and respiratory disease that have been documented elsewhere, including asthma, COPD, and some respiratory infections such as pneumonia.11, 12 As with other studies, positive associations were found between wildfire smoke and asthma, COPD, pneumonia, and respiratory‐related chest pain symptoms. In 1 study of long‐term wildfire‐PM2.5 exposure and asthma, adult women were found to be at greatest risk of asthma‐related ED visits. Differential impacts of wildfire‐ and urban‐PM2.5 are still being explored; 1 study found increased pulmonary toxicity of wildfire‐PM2.5 compared with background urban sources in an animal model.48 In addition to differences in component particles in PM2.5 between urban and wildfire sources, urban exposures can be an order of magnitude lower but more persistent over time, while wildfire particulate exposure can vary significantly, peaking at much higher levels.49, 50
We also used acute appendicitis and long‐bone fractures as control conditions that were not expected to be associated with wildfire‐PM2.5 given their inflammation‐ and coagulation‐independent pathophysiology. No association was found with acute appendicitis but acute appendicitis events were rare and the resulting CIs were wide. Interestingly, an association was found with long‐bone fractures and wildfire smoke among older adults at lag 0. Another study has used bone fractures as a control condition and while their results were not statistically significant, risk of bone fractures among all adults exposed to wildfire smoke was increased (RR 1.06, 95% CI: 0.97–1.15).26 This could be because of trauma or falls, particularly among older adults, in the context of the wildfire response or evacuation. Motor vehicle accidents, for example, may precipitate long‐bone fractures and may be more common during wildfire smoke events and evacuations, during which “superfog”—a combination of smoke and precipitation—may form at the ground level and can drastically reduce visibility on roadways.51 Additionally, cardiac and cerebrovascular events can also precipitate falls and, given the associations found with cardiac dysrhythmias and other cardiac outcomes in this study, may offer another explanation for the surprising association with long‐bone fractures. Based on the number of appendicitis‐related visits and the possible connection between cardiovascular outcomes and bone fractures among older adults, we interpret the results for these conditions with these considerations in mind.
A major strength of this study was using data from the entirety of the 2015 wildfire season across a large area of California, during which a substantial population was exposed to a particularly intense season. This may have increased the statistical power of detecting rare health events, such as the cardiovascular and cerebrovascular effects observed in this study. The HMS data set provided estimates of smoke density on a smaller spatial resolution compared with the ground‐based monitoring data, particularly in rural areas of California, where wildfires were more prevalent and monitors less so. In some instances, an individual county may have only 1 ground‐based air monitor for PM2.5. In addition, the OSHPD healthcare utilization data provided comprehensive state‐wide data of ED visits based on discharge diagnoses, whereas some other studies have relied upon syndromic surveillance.16, 26, 52 One study evaluated syndromic surveillance for cardiovascular disease in New York City and found high specificity for many of the disease entities, but often a low sensitivity and positive‐predictive value, which may underestimate the impact of wildfire smoke on cardiovascular disease.53
This analysis is not without limitations. In the current analysis, because we focused on age‐stratified and specific cardiovascular outcomes, we were not able to further refine daily counts of ED visits by other factors. For example, we did not examine the effect of personal traits or characteristics such as socioeconomic status, past medical history, race, sex and other factors that may modify the association between daily variation in smoke exposure and ED visits. The modifying effect of these factors has previously been observed and discussed in the literature.11, 25, 54 However, we did examine the sensitivity of these results to the confounding by socioeconomic status, such as poverty, and did not find evidence of confounding between poverty, smoke exposure, and health outcomes (Table S3).
The HMS data set provides smoke plume density based on estimated PM2.5 concentrations and is characterized as light, medium, and dense smoke, where cutoff points are chosen with some degree of subjectivity.21 These categorical exposure estimates made it difficult to complete a more nuanced assessment of incremental changes in PM2.5 or other air pollutants on outcomes. Additionally, the number of smoky days was not evenly distributed between the different smoke levels, leading to wider CIs among dense smoke results and making the evaluation of a dose‐dependent response more challenging.
The HMS data, however, are convenient, publicly available, and obtained via remote sensors providing more complete, timely data compared with other publicly available ground‐based sources in California. Additionally, HMS data provide a classification of categorical smoke density which is a convenient representation for the purposes of making timely public health announcements. The results of the current analysis suggest that development of rapid ground‐level air pollutant concentration validation methods based on satellite data could potentially be beneficial to public health risk messaging.
While PM2.5 is a primary pollutant of concern from the perspective of population wide exposures, smoke plumes contain other pollutants that have known impacts on respiratory outcomes, such as ozone, nitrogen dioxide, carbon monoxide, coarse particulate matter (PM10‐2.5), and ultrafine particulate matter (0.1 μm or less). These pollutants may play an interactive role with PM2.5 on health outcomes. However, other air pollutants are measured to a lesser extent with poor geographic and spatial coverage. Additionally, a recent study demonstrated that PM2.5 estimates alone significantly underestimated the particulate matter emissions of wildfire smoke plumes in the western United States by a factor of 2 to 3.19 Therefore, examining health effects based on plume density as visible by satellites may have its own advantages as the plume may represent multiple air pollutants emitted from the fire. Future research would benefit from an inclusion of co‐pollutant exposure in the analysis when such data are available.
These results may be useful for public health practitioners in decision‐making surrounding risk mitigation during wildfire smoke events. Hospital administrators may find this information helpful for hospital and emergency department surge planning for increased volume, including staffing, bed utilization, and discharge challenges during ongoing wildfires. Similarly, stroke centers and hospitals with cardiac catheterization capabilities may find these results applicable to surge preparation.
On the level of the individual patient, the Center for Medicaid and Medicare Services and the Centers for Disease Control and Prevention, as part of the Million Hearts® 2022 framework (https://millionhearts.hhs.gov/files/MH-Framework.pdf), have identified counseling of patients and family on the risks of airborne particulate matter, along with nutrition, physical activity, tobacco use, and referral to community‐based physical activity programs and cardiac rehabilitation, as healthcare strategies to optimize care. Healthcare professionals may benefit from utilizing these results for patient risk stratification and subsequent education on risk mitigation for optimizing health care in the context of wildfire smoke exposure. Interventions for higher‐risk individuals range from the well‐established, such as evacuation from the affected area or transport to a clean air shelter, and reduction of outdoor activity, to other methods under study, such as indoor air filtration of fine particulates or use of N‐95 respirators.55, 56 Further study is needed to define patient populations at increased risk for specific events, but these results suggest that patients with vascular and cardiac risk factors would be among the most susceptible, including patients with underlying coronary artery disease, heart failure, peripheral vascular disease, atrial fibrillation, cerebrovascular disease, hypertension, and diabetes mellitus.18
Conclusions
Time‐series analysis was conducted of wildfire smoke and emergency department visits for the 2015 wildfire season in northern and central California. Despite the inconsistent findings discussed elsewhere, in this study wildfire smoke exposure was found to be positively associated with many cardiovascular and cerebrovascular health events, including ischemic heart disease, dysrhythmia, heart failure, and pulmonary embolism. Impacts were greatest among adults ≥65 years. This epidemiologic evidence helps strengthen the association between wildfire smoke exposure and cardiovascular disease outcomes and highlights the increased risk to the older population. These findings, along with others, support the need for clinical research to assess the clinical and public health value of interventions to decrease exposure to particulate matter, and particularly to wildfire smoke, among those at highest risk.11, 12, 55, 57, 58, 59 As wildfire season intensity and duration is projected to increase in California, understanding adverse health impacts of wildfire smoke and identifying the most susceptible populations is relevant to a broad group of stakeholders, including state and local officials responsible for land and air quality management, environmental scientists, policy makers, public health officials, and frontline public health and healthcare practitioners.
Acknowledgments
The research described in this article has been reviewed by the National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the Agency, nor does the mention of trade names of commercial products constitute endorsement or recommendation for use.
Supplemental Material
File (jah33054-sup-0001-tabless1-s3.pdf)
- Download
- 507.83 KB
References
1.
Westerling AL, Hidalgo HG, Cayan DR, Swetnam TW. Warming and earlier spring increase western U.S. forest wildfire activity. Science. 2006;313:940–943.
2.
Westerling AL, Bryant BP, Preisler HK, Holmes TP, Hidalgo HG, Das T, Shrestha SR. Climate change and growth scenarios for California wildfire. Clim Change. 2011;109:445–463.
3.
Westerling AL, Bryant BP. Climate change and wildfire in California. Clim Change. 2008;87:231–249.
4.
Fisk WJ. Review of some effects of climate change on indoor environmental quality and health and associated no‐regrets mitigation measures. Build Environ. 2015;86:70–80.
5.
Fann N, Alman B, Broome RA, Morgan GG, Johnston FH, Pouliot G, Rappold AG. The health impacts and economic value of wildland fire episodes in the U.S.: 2008–2012. Sci Total Environ. 2017;610–611:802–809.
6.
Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, Koenig JQ, Smith KR. Woodsmoke health effects: a review. Inhal Toxicol. 2007;19:67–106.
7.
Jerrett M, Burnett RT, Pope CA, Ito K, Thurston G, Krewski D, Shi Y, Calle E, Thun M. Long‐term ozone exposure and mortality. N Engl J Med. 2009;360:1085–1095.
8.
Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, Balakrishnan K, Brunekreef B, Dandona L, Dandona R, Feigin V, Freedman G, Hubbell B, Jobling A, Kan H, Knibbs L, Liu Y, Martin R, Morawska L, Pope CA III, Shin H, Straif K, Shaddick G, Thomas M, van Dingenen R, van Donkelaar A, Vos T, Murray CJL, Forouzanfar MH. Estimates and 25‐year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389:1907–1918.
9.
Mills IC, Atkinson RW, Anderson HR, Maynard RL, Strachan DP. Distinguishing the associations between daily mortality and hospital admissions and nitrogen dioxide from those of particulate matter: a systematic review and meta‐analysis. BMJ Open. 2016;6:e010751.
10.
Cai Y, Zhang B, Ke W, Feng B, Lin H, Xiao J, Zeng W, Li X, Tao J, Yang Z, Ma W, Liu T. Associations of short‐term and long‐term exposure to ambient air pollutants with hypertension novelty and significance: a systematic review and meta‐analysis. Hypertension. 2016;68:62–70.
11.
Reid CE, Brauer M, Johnston F, Jerrett M, Balmes JR, Elliott CT. Critical review of health impacts of wildfire smoke exposure. Environ Health Perspect. 2016;124:1334–1343.
12.
Liu JC, Pereira G, Uhl SA, Bravo MA, Bell ML. A systematic review of the physical health impacts from non‐occupational exposure to wildfire smoke. Environ Res. 2015;136:120–132.
13.
Alman BL, Pfister G, Hao H, Stowell J, Hu X, Liu Y, Strickland MJ. The association of wildfire smoke with respiratory and cardiovascular emergency department visits in Colorado in 2012: a case crossover study. Environ Health. 2016;15:64.
14.
Finlay SE, Moffat A, Gazzard R, Baker D, Murray V. Health impacts of wildfires. PLoS Curr. 2012;4:e4f959951cce2c.
15.
Haikerwal A, Akram M, Del Monaco A, Smith K, Sim MR, Meyer M, Tonkin AM, Abramson MJ, Dennekamp M. Impact of fine particulate matter (PM2. 5) exposure during wildfires on cardiovascular health outcomes. J Am Heart Assoc. 2015;4:e001653.
16.
Rappold AG, Stone SL, Cascio WE, Neas LM, Kilaru VJ, Carraway MS, Szykman JJ, Ising A, Cleve WE, Meredith JT, Vaughan‐Batten H, Deyneka L, Devlin RB. Peat bog wildfire smoke exposure in rural North Carolina is associated with cardiopulmonary emergency department visits assessed through syndromic surveillance. Environ Health Perspect. 2011;119:1415.
17.
Sacks JD, Stanek LW, Luben TJ, Johns DO, Buckley BJ, Brown JS, Ross M. Particulate matter‐induced health effects: who is susceptible? Environ Health Perspect. 2010;119:446–454.
18.
Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez‐Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease. Circulation. 2010;121:2331–2378.
19.
Liu X, Huey LG, Yokelson RJ, Selimovic V, Simpson IJ, Müller M, Jimenez JL, Campuzano‐Jost P, Beyersdorf AJ, Blake DR, Butterfield Z, Choi Y, Crounse JD, Day DA, Diskin GS, Dubey MK, Fortner E, Hanisco TF, Hu W, King LE, Kleinman L, Meinardi S, Mikoviny T, Onasch TB, Palm BB, Peischl J, Pollack IB, Ryerson TB, Sachse GW, Sedlacek AJ, Shilling JE, Springston S, St. Clair JM, Tanner DJ, Teng AP, Wennberg PO, Wisthaler A, Wolfe GM. Airborne measurements of western U.S. wildfire emissions: comparison with prescribed burning and air quality implications: western U.S. wildfire emissions. J Geophys Res Atmos. 2017;122:6108–6129.
20.
Resnick A, Woods B, Krapfl H, Toth B. Health outcomes associated with smoke exposure in Albuquerque, New Mexico, during the 2011 Wallow fire. J Public Health Manag Pract. 2015;21:S55–S61.
21.
Ruminski M, Kondragunta S, Draxler R, Rolph G. Use of environmental satellite imagery for smoke depiction and transport model initialization. In: 16th Annual International Emission Inventory Conf.: Emission Inventories—Integration, Analysis, and Communications; 2007. Available at: http://www.academia.edu/download/39927040/Use_of_environmental_satellite_imagery_f20151112-11478-1bxghhw.pdf. Accessed April 23, 2017.
22.
Knapp KR, Frouin R, Kondragunta S, Prados A. Toward aerosol optical depth retrievals over land from GOES visible radiances: determining surface reflectance. Int J Remote Sens. 2005;26:4097–4116.
23.
Tirschwell DL, Longstreth WT. Validating administrative data in stroke research. Stroke. 2002;33:2465–2470.
24.
Andrade SE, Harrold LR, Tjia J, Cutrona SL, Saczynski JS, Dodd KS, Goldberg RJ, Gurwitz JH. A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf. 2012;21:100–128.
25.
Reid CE, Jerrett M, Tager IB, Petersen ML, Mann JK, Balmes JR. Differential respiratory health effects from the 2008 northern California wildfires: a spatiotemporal approach. Environ Res. 2016;150:227–235.
26.
Tinling MA, West JJ, Cascio WE, Kilaru V, Rappold AG. Repeating cardiopulmonary health effects in rural North Carolina population during a second large peat wildfire. Environ Health. 2016;15:12.
27.
Anderson GB, Bell ML, Peng RD. Methods to calculate the heat index as an exposure metric in environmental health research. Environ Health Perspect. 2013;121:1111–1119.
28.
Peng RD, Dominici F, Louis TA. Model choice in time series studies of air pollution and mortality. J R Stat Soc Ser A Stat Soc. 2006;169:179–203.
29.
Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long‐term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71–77.
30.
Martinelli N, Olivieri O, Girelli D. Air particulate matter and cardiovascular disease: a narrative review. Eur J Intern Med. 2013;24:295–302.
31.
Li W, Wilker EH, Dorans KS, Rice MB, Schwartz J, Coull BA, Koutrakis P, Gold DR, Keaney JF, Lin H, Vasan RS, Benjamin EJ, Mittleman MA. Short‐term exposure to air pollution and biomarkers of oxidative stress: the Framingham Heart Study. J Am Heart Assoc. 2016;5:e002742. DOI :.
32.
Pope CA, Muhlestein JB, Anderson JL, Cannon JB, Hales NM, Meredith KG, Le V, Horne BD. Short‐term exposure to fine particulate matter air pollution is preferentially associated with the risk of ST‐segment elevation acute coronary events. J Am Heart Assoc. 2015;4:e002506.
33.
Hartiala J, Breton CV, Tang WHW, Lurmann F, Hazen SL, Gilliland FD, Allayee H. Ambient air pollution is associated with the severity of coronary atherosclerosis and incident myocardial infarction in patients undergoing elective cardiac evaluation. J Am Heart Assoc. 2016;5:e003947.
34.
He F, Shaffer ML, Rodriguez‐Colon S, Yanosky JD, Bixler E, Cascio WE, Liao D. Acute effects of fine particulate air pollution on cardiac arrhythmia: the APACR study. Environ Health Perspect. 2011;119:927–932.
35.
Schneider A, Neas LM, Graff DW, Herbst MC, Cascio WE, Schmitt MT, Buse JB, Peters A, Devlin RB. Association of cardiac and vascular changes with ambient PM 2.5 in diabetic individuals. Part Fibre Toxicol. 2010;7:14.
36.
Pieters N, Plusquin M, Cox B, Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta‐analysis. Heart. 2012;98:1127–1135.
37.
Gardner B, Ling F, Hopke PK, Frampton MW, Utell MJ, Zareba W, Cameron SJ, Chalupa D, Kane C, Kulandhaisamy S, Topf MC, Rich DQ. Ambient fine particulate air pollution triggers ST‐elevation myocardial infarction, but not non‐ST elevation myocardial infarction: a case‐crossover study. Part Fibre Toxicol. 2014;11:1.
38.
Shah AS, Langrish JP, Nair H, McAllister DA, Hunter AL, Donaldson K, Newby DE, Mills NL. Global association of air pollution and heart failure: a systematic review and meta‐analysis. Lancet. 2013;382:1039–1048.
39.
Giorgini P, Di Giosia P, Grassi D, Rubenfire M, Brook RD, Ferri C. Air pollution exposure and blood pressure: an updated review of the literature. Curr Pharm Des. 2016;22:28–51.
40.
Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002;105:1534–1536.
41.
Rich DQ, Freudenberger RS, Ohman‐Strickland P, Cho Y, Kipen HM. Right heart pressure increases after acute increases in ambient particulate concentration. Environ Health Perspect. 2008;116:1167–1171.
42.
Dennekamp M, Straney LD, Erbas B, Abramson MJ, Keywood M, Smith K, Sim MR, Glass DC, Del Monaco A, Haikerwal A, Tonkin AM. Forest fire smoke exposures and out‐of‐hospital cardiac arrests in Melbourne, Australia: a case‐crossover study. Environ Health Perspect. 2015;123:959–964.
43.
Delfino RJ, Brummel S, Wu J, Stern H, Ostro B, Lipsett M, Winer A, Street DH, Zhang L, Tjoa T, Gillen DL. The relationship of respiratory and cardiovascular hospital admissions to the southern California wildfires of 2003. Occup Environ Med. 2009;66:189–197.
44.
Lee T‐S, Falter K, Meyer P, Mott J, Gwynn C. Risk factors associated with clinic visits during the 1999 forest fires near the Hoopa Valley Indian Reservation, California, USA. Int J Environ Health Res. 2009;19:315–327.
45.
Straney L, Finn J, Dennekamp M, Bremner A, Tonkin A, Jacobs I. Evaluating the impact of air pollution on the incidence of out‐of‐hospital cardiac arrest in the Perth Metropolitan Region: 2000–2010. J Epidemiol Community Health. 2014;68:6–12.
46.
Johnston FH, Purdie S, Jalaludin B, Martin KL, Henderson SB, Morgan GG. Air pollution events from forest fires and emergency department attendances in Sydney, Australia 1996–2007: a case‐crossover analysis. Environ Health. 2014;13:1.
47.
Morgan G, Sheppeard V, Khalaj B, Ayyar A, Lincoln D, Jalaludin B, Beard J, Corbett S, Lumley T. Effects of bushfire smoke on daily mortality and hospital admissions in Sydney, Australia. Epidemiology. 2010;21:47–55.
48.
Wegesser TC, Pinkerton KE, Last JA. California wildfires of 2008: coarse and fine particulate matter toxicity. Environ Health Perspect. 2009;117:893–897.
49.
Reisen F, Brown SK. Implications for community health from exposure to bushfire air toxics. Environ Chem. 2006;3:235–243.
50.
Johnston F, Hanigan I, Henderson S, Morgan G, Bowman D. Extreme air pollution events from bushfires and dust storms and their association with mortality in Sydney, Australia 1994–2007. Environ Res. 2011;111:811–816.
51.
Achtemeier GL. On the formation and persistence of superfog in woodland smoke. Meteorol Appl. 2009;16:215–225.
52.
Thelen B, French NH, Koziol BW, Billmire M, Owen RC, Johnson J, Ginsberg M, Loboda T, Wu S. Modeling acute respiratory illness during the 2007 San Diego wildland fires using a coupled emissions‐transport system and generalized additive modeling. Environ Health. 2013;12:1.
53.
Mathes RW, Ito K, Matte T. Assessing syndromic surveillance of cardiovascular outcomes from emergency department chief complaint data in New York City. PLoS One. 2011;6:e14677.
54.
Rappold AG, Cascio WE, Kilaru VJ, Stone SL, Neas LM, Devlin RB, Diaz‐Sanchez D. Cardio‐respiratory outcomes associated with exposure to wildfire smoke are modified by measures of community health. Environ Health. 2012;11:71.
55.
Fisk WJ, Chan WR. Health benefits and costs of filtration interventions that reduce indoor exposure to PM2.5 during wildfires. Indoor Air. 2017;27:191–204.
56.
Mentz RJ, O'Brien EC. Air pollution in patients with heart failure. JACC Heart Fail. 2016;4:65–67.
57.
Fisk WJ, Chan WR. Effectiveness and cost of reducing particle‐related mortality with particle filtration. Indoor Air. 2017;27:909–920.
58.
Barn PK, Elliott CT, Allen RW, Kosatsky T, Rideout K, Henderson SB. Portable air cleaners should be at the forefront of the public health response to landscape fire smoke. Environ Health. 2016;15:116.
59.
Brook RD, Newby DE, Rajagopalan S. The global threat of outdoor ambient air pollution to cardiovascular health: time for intervention. JAMA Cardiol. 2017;2:353–354.
Information & Authors
Information
Published In
Copyright
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
History
Received: 28 August 2017
Accepted: 16 February 2018
Published online: 11 April 2018
Published in print: 17 April 2018
Keywords
Subjects
Authors
Disclosures
None.
Funding Information
National Center for Advancing Translational Sciences
National Institutes of Health, through UCSF‐CTSI: TL1 TR001871
This publication was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF‐CTSI Grant Number TL1 TR001871. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or the California Department of Public Health.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Killer Congestion: Temperature, Healthcare Utilization and Patient Outcomes, SSRN Electronic Journal, (2025).https://doi.org/10.2139/ssrn.5140738
- Perceived wildfire risk and past experiences with wildfire smoke influence public support for prescribed burning in the western conterminous United States, BMC Public Health, 25, 1, (2025).https://doi.org/10.1186/s12889-025-21295-5
- Impact of Canadian Wildfire-Emitted Particulate Matter on THP-1 Lung Macrophage Health and Function, Environmental Science & Technology, 59, 8, (3869-3883), (2025).https://doi.org/10.1021/acs.est.4c10304
- Health challenges of climate change in the Eastern Mediterranean and Middle East region, with a focus on Türkiye. An environmental neurological and brain health perspective, Journal of the Neurological Sciences, 470, (123423), (2025).https://doi.org/10.1016/j.jns.2025.123423
- Associations of wildfire-derived particulate matter with hospitalization, emergency department visits and mortality: A systematic review and meta-analysis, Environmental Research, 273, (121221), (2025).https://doi.org/10.1016/j.envres.2025.121221
- Los Angeles Wildfires: Getting to the Heart of It, The American Journal of Medicine, (2025).https://doi.org/10.1016/j.amjmed.2025.02.028
- The Short-Term Impacts of the 2017 Portuguese Wildfires on Human Health and Visibility: A Case Study, Fire, 7, 10, (342), (2024).https://doi.org/10.3390/fire7100342
- The Impact of Air Pollution from Industrial Fires in Urban Settings: Monitoring, Modelling, Health, and Environmental Justice Perspectives, Environments, 11, 7, (157), (2024).https://doi.org/10.3390/environments11070157
- Daily Fine Resolution Estimates of the Influence of Wildfires on Fine Particulate Matter in California, 2011–2020, Atmosphere, 15, 6, (680), (2024).https://doi.org/10.3390/atmos15060680
- Fired Up or Burned Down: Wildfires and VC Investment, SSRN Electronic Journal, (2024).https://doi.org/10.2139/ssrn.4807813
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.